Discover
INSP
Inspire Medical Systems, Inc.
56.31
500 x 53.20
600 x 56.68
bid
ask
-
0.04
0.07%
550 @ 04:00 PM
57.00 +0.69 (1.23%)
| Ytd | -38.95% | |
| 1y | -64.41% |
55.06
day range
57.00
50.13
52 week range
161.88
| Open | 56.15 | Prev Close | 56.35 | Low | 55.06 | High | 57.00 | Mkt Cap | 1.62B |
| Vol | 579.25K | Avg Vol | 1.18M | EPS | 4.89 | P/E | 11.52 | Forward P/E | 21.81 |
| Beta | 0.86 | Short Ratio | 3.37 | Inst. Own | 121.13% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-04 | 50-d Avg | 57.52 | 200-d Avg | 85.53 | 1yr Est | 72.25 |
Earning
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2026-05-04 | 2026-03 | 0 | N/A | N/A | N/A |
| 2026-02-11 | 2025-12 | 0.69 | 1.65 | 0.96 | 139.13% |
| 2025-11-03 | 2025-09 | 0 | 0.38 | 0.53 | 353.33% |
| 2025-11-03 | 2025-09 | 0 | N/A | N/A | N/A |
| 2025-08-04 | 2025-06 | 0.22 | 0.45 | 0.23 | 104.55% |
| 2025-08-04 | 2025-06 | 0.22 | N/A | N/A | N/A |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| 2026-04-15 | Truist Securities | Upgrade | Hold | Hold |
| 2026-04-13 | Mizuho | Upgrade | Outperform | Outperform |
| 2026-04-10 | Stifel | Upgrade | Buy | Buy |
| 2026-04-06 | Evercore ISI Group | Upgrade | Outperform | Outperform |
| 2026-03-05 | Stifel | Upgrade | Buy | Buy |
| 2026-02-13 | Wolfe Research | Downgrade | Outperform | Peer Perform |
Profile
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Insider Holder
| Date | Name | Relation | Quantity | Description |
|---|---|---|---|---|
| 2025-08-28 | BUCHHOLZ RICHARD | Chief Financial Officer | 50.77K | Sale |
| 2026-02-19 | HERBERT TIMOTHY P | Chief Executive Officer | 163.49K | Stock Award(Grant) |
| 2026-02-19 | MANN MELISSA | Officer | 23.61K | Stock Award(Grant) |
| 2025-12-01 | MCCORMICK SHAWN T | Director | 27.85K | Sale |
| 2025-04-30 | MEAD DANA G JR | Director | 22.65K | Stock Award(Grant) |
| 2024-04-28 | NELSON MARILYN CARLSON | Director | 86.54K | Conversion of Exercise of derivative security |
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2025-12-30 | Blackrock Inc. | 3.55M | 199.81M | 12.33% |
| 2025-12-30 | Vanguard Group Inc | 2.95M | 166.17M | 10.26% |
| 2025-12-30 | Wellington Management Group, LLP | 2.21M | 124.42M | 7.68% |
| 2025-12-30 | Deerfield Management Company, L.P | 1.51M | 84.74M | 5.23% |
| 2025-12-30 | Morgan Stanley | 1.26M | 70.89M | 4.38% |
| 2025-12-30 | Shaw D.E. & Co., Inc. | 1.21M | 68.21M | 4.21% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2026-02-27 | iShares Trust-iShares Core S&P Small-Cap ETF | 1.61M | 90.37M | 5.58% |
| 2026-01-30 | VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund | 1.09M | 61.56M | 3.80% |
| 2025-12-30 | VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 899.59K | 50.62M | 3.12% |
| 2026-01-30 | Vanguard Explorer Fund | 761.65K | 42.86M | 2.65% |
| 2025-12-30 | VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 658.80K | 37.07M | 2.29% |
| 2025-11-29 | VANGUARD WORLD FUND-Vanguard U.S. Growth Fund | 577.84K | 32.51M | 2.01% |
Dividend
| Dividend | Date |
|---|---|
| 9 | 2008-01-09 |
